Calls Now Open
2027 Scholar-Innovator
May 20, 2026
[image:1] A former British prime minister, a Cleveland sports owner, and a race to cure diseases that have stumped science Former British PM David Cameron brings his personal mission to Cleveland as a major rare disease conference begins at the Cleveland Museum of Natural History. CLEVELAND — When Lord David Cameron...
Continue Reading
July 09, 2025
Experimental Compound Offers Potential Treatment for Rare, Often Fatal, Childhood Disease Continue Reading
July 09, 2025
Decreased brain levels of coenzyme Q10 (CoQ10), an endogenously synthesized lipophilic antioxidant, underpin encephalopathy in primary CoQ10 deficiencies and are associated with common neurodegenerative diseases and the ageing process. Continue Reading
June 19, 2025
Enzymes that regulate oncogenic protein function through the addition of post-translational modifications (PTMs) represent promising targets for the development of cancer therapeutics. Continue Reading
June 04, 2025
The former prime minister has called for children admitted to paediatric care to undergo genome sequencing as part of a drive to cure 40 rare diseases Continue Reading
May 21, 2025
Alzheimer’s disease (AD) and traumatic brain injury (TBI) are currently untreatable neurodegenerative disorders afflicting millions of people worldwide. These conditions are pathologically related, and TBI is one of the greatest risk factors for AD. Continue Reading
January 27, 2025
At 18 weeks pregnant, Lindsey learned her baby had severe spina bifida. She joined UC Davis’s groundbreaking CuRe Trial combining fetal surgery and stem cells. Over a year later, her son is thriving. Continue Reading
December 11, 2024
An off-the-shelf drug shows promise as a low-cost topical treatment for psoriasis. New findings highlight benzamil’s potential to reduce inflammation and skin cell overgrowth without steroids or immune suppression. Continue Reading
September 17, 2024
Progression of acute TBI to chronic neurodegeneration is a major health problem with no protective treatments. Time sensitive inhibition of acutely elevated mitochondrial fission may present a way to protect patients from chronic neurodegeneration. Continue Reading
July 16, 2024
There’s only one U.S. Food and Drug Administration-approved therapy for an inherited retinal disease, and dozens of retinitis pigmentosa (RP) genes for which no therapy is available. Continue Reading
March 25, 2024
Nature Chemical Biology, published March 25, 2024 Continue Reading